会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明授权
    • N-substituted-2-oxodihydropyridine derivatives
    • N-取代-2-氧代二氢吡啶衍生物
    • US07138525B2
    • 2006-11-21
    • US10899162
    • 2004-07-27
    • Nagaaki SatoMakoto AndoShiho IshikawaTsuyoshi NagaseKeita NagaiAkio Kanatani
    • Nagaaki SatoMakoto AndoShiho IshikawaTsuyoshi NagaseKeita NagaiAkio Kanatani
    • C07D211/80
    • C07D213/80C07D401/04C07D401/14
    • A compound of the formula (I): (wherein Ar1 and Ar2 are independently aryl or heteroaryl, any of which is optionally substituted by a substituent selected from the group consisting of cyano, halogen, nitro, lower alkyl, halo-lower alkyl, hydroxy-lower alkyl, cyclo-lower alkyl, cyclo(lower alkyl)-lower alkyl, lower alkenyl, lower alkylamino, di-lower alkylamino, lower alkanoylamino, lower alkylsulfonylamino, arylsulfonylamino, hydroxy, lower alkoxy, halo-lower alkoxy, aryloxy, heteroaryloxy, lower alkylthio, carboxyl, formyl, lower alkanoyl, lower alkoxycarbonyl, carbamoyl, lower alkylcarbamoyl, di-lower alkylcarbamoyl, lower alkylsulfonyl, arylsulfonyl, aryl and heteroaryl; R1 and R2 are independently lower alkyl, cyclo-lower alkyl, cyclo(lower alkyl)-lower alkyl or lower alkoxy, any of which is optionally substituted by a substituent selected from the group consisting of halogen, lower alkylamino, di-lower alkylamino, lower alkanoylamino, hydroxy, lower alkoxy, formyl, lower alkoxycarbonyl, lower alkylcarbamoyl and di-lower alkylcarbamoyl; R3, R4 and R5 are independently hydrogen, cyano, halogen or hydroxy, or lower alkyl, lower alkoxy or lower alkylthio, the last three groups being optionally substituted by a substituent selected from the group consisting of halogen, lower alkylamino, di-lower alkylamino, lower alkanoylamino, hydroxy, lower alkoxy, formyl, lower alkoxycarbonyl, lower alkylcarbamoyl and di-lower alkylcarbamoyl), or a salt or ester thereof is useful as a neuropeptide Y receptor antagonist agent and is also useful as an agent for the treatment of bulimia, obesity or diabetes.
    • 式(I)的化合物:其中Ar 1和Ar 2独立地为芳基或杂芳基,其中任何一个任选被选自以下的取代基取代: 氰基,卤素,硝基,低级烷基,卤代低级烷基,羟基 - 低级烷基,环 - 低级烷基,环(低级烷基) - 低级烷基,低级烯基,低级烷基氨基,二低级烷基氨基,低级烷酰基氨基,低级烷基磺酰基氨基 ,芳基磺酰基氨基,羟基,低级烷氧基,卤代低级烷氧基,芳氧基,杂芳氧基,低级烷硫基,羧基,甲酰基,低级烷酰基,低级烷氧基羰基,氨基甲酰基,低级烷基氨基甲酰基,二低级烷基氨基甲酰基,低级烷基磺酰基,芳基磺酰基,芳基和杂芳基; R R 1和R 2独立地是低级烷基,环 - 低级烷基,环(低级烷基) - 低级烷基或低级烷氧基,其中任何一个任选被选定的取代基取代 由卤素,低级烷基氨基,二低级烷基氨基,低级烷酰氨基,低级烷基氨基, 低级烷氧基,甲酰基,低级烷氧基羰基,低级烷基氨基甲酰基和二低级烷基氨基甲酰基; R 3,R 4和R 5独立地是氢,氰基,卤素或羟基,或低级烷基,低级烷氧基或低级烷硫基, 最后三个基团任选被选自卤素,低级烷基氨基,二低级烷基氨基,低级烷酰基氨基,羟基,低级烷氧基,甲酰基,低级烷氧基羰基,低级烷基氨基甲酰基和二低级烷基氨基甲酰基的取代基取代)或盐 或其酯可用作神经肽Y受体拮抗剂,并且也可用作治疗贪食症,肥胖症或糖尿病的药剂。
    • 10. 发明申请
    • N-substituted-2-oxodihydropyridine derivatives
    • N-取代-2-氧代二氢吡啶衍生物
    • US20050009879A1
    • 2005-01-13
    • US10899162
    • 2004-07-27
    • Nagaaki SatoMakoto AndoShiho IshikawaTsuyoshi NagaseKeita NagaiAkio Kanatani
    • Nagaaki SatoMakoto AndoShiho IshikawaTsuyoshi NagaseKeita NagaiAkio Kanatani
    • A61P3/04C07D213/80C07D401/04C07D401/14A61K31/4439C07
    • C07D213/80C07D401/04C07D401/14
    • A compound of the formula (I): (wherein Ar1 and Ar2 are independently aryl or heteroaryl, any of which is optionally substituted by a substituent selected from the group consisting of cyano, halogen, nitro, lower alkyl, halo-lower alkyl, hydroxy-lower alkyl, cyclo-lower alkyl, cyclo(lower alkyl)-lower alkyl, lower alkenyl, lower alkylamino, di-lower alkylamino, lower alkanoylamino, lower alkylsulfonylamino, arylsulfonylamino, hydroxy, lower alkoxy, halo-lower alkoxy, aryloxy, heteroaryloxy, lower alkylthio, carboxyl, formyl, lower alkanoyl, lower alkoxycarbonyl, carbamoyl, lower alkylcarbamoyl, di-lower alkylcarbamoyl, lower alkylsulfonyl, arylsulfonyl, aryl and heteroaryl; R1 and R2 are independently lower alkyl, cyclo-lower alkyl, cyclo(lower alkyl)-lower alkyl or lower alkoxy, any of which is optionally substituted by a substituent selected from the group consisting of halogen, lower alkylamino, di-lower alkylamino, lower alkanoylamino, hydroxy, lower alkoxy, formyl, lower alkoxycarbonyl, lower alkylcarbamoyl and di-lower alkylcarbamoyl; R3, R4 and R5 are independently hydrogen, cyano, halogen or hydroxy, or lower alkyl, lower alkoxy or lower alkylthio, the last three groups being optionally substituted by a substituent selected from the group consisting of halogen, lower alkylamino, di-lower alkylamino, lower alkanoylamino, hydroxy, lower alkoxy, formyl, lower alkoxycarbonyl, lower alkylcarbamoyl and di-lower alkylcarbamoyl), or a salt or ester thereof is useful as a neuropeptide Y receptor antagonist agent and is also useful as an agent for the treatment of bulimia, obesity or diabetes.
    • 式(I)的化合物:其中Ar 1和Ar 2独立地为芳基或杂芳基,其中任何一个任选被选自氰基,卤素,硝基,低级烷基, 卤代低级烷基,羟基 - 低级烷基,环 - 低级烷基,环(低级烷基) - 低级烷基,低级烯基,低级烷基氨基,二低级烷基氨基,低级烷酰基氨基,低级烷基磺酰基氨基,芳基磺酰基氨基,羟基,低级烷氧基, 低级烷氧基,芳氧基,杂芳氧基,低级烷硫基,羧基,甲酰基,低级烷酰基,低级烷氧基羰基,氨基甲酰基,低级烷基氨基甲酰基,二低级烷基氨基甲酰基,低级烷基磺酰基,芳基磺酰基,芳基和杂芳基; R 1和R 2独立地为 低级烷基,环 - 低级烷基,环(低级烷基) - 低级烷基或低级烷氧基,其中任何一个任选被选自卤素,低级烷基氨基,二低级烷基氨基,低级烷酰氨基,羟基, 低级烷氧基,甲酰基,低级烷基 低级烷基氨基甲酰基和二低级烷基氨基甲酰基; R 3,R 4和R 5独立地是氢,氰基,卤素或羟基,或低级烷基,低级烷氧基或低级烷硫基,最后三个基团任选地被选自以下的取代基取代: 卤素,低级烷基氨基,二低级烷基氨基,低级烷酰基氨基,羟基,低级烷氧基,甲酰基,低级烷氧基羰基,低级烷基氨基甲酰基和二低级烷基氨基甲酰基)或其盐或酯可用作神经肽Y受体拮抗剂, 可用作治疗贪食症,肥胖症或糖尿病的药剂。